EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Clinicopathological Analysis of Asian Patients with Adrenocortical Carcinoma: A Single-Center Experience

Wen-Hsuan Tsai iD, Shuen-Han Dai, Chun-Chuan Lee, Ming-Nan Chien, Yi-Hong Zeng

Current Oncology · 2023

DOI: 10.3390/curroncol30040313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, 2023. Verfasst von Wen-Hsuan Tsai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, MacKay Memorial Hospital, Taipei 104, Taiwan. Hauptthemen laut MEDLINE: Adrenocortical Carcinoma, Adrenal Cortex Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is limited information regarding the immunohistochemistry stain and its prognostic role in adrenocortical carcinoma (ACC), and few studies focus on Asian patients. Our study aims to identify the correlation between immunohistochemistry staining and the prognosis of ACC in Asian patients.

Methods

We searched the database of a single center in Taiwan for cases with a pathological diagnosis of ACC in the past 25 years. We collected patient data on age, sex, initial presentation, staging, metastatic site, and survival duration. Immunohistochemical studies using antibodies to CDK4, ATRX, beta-catenin, Ki-67, SSTR2, and p53 were performed. Survival analysis was performed using the log-rank test, the Cox proportional hazards model and bootstrapping with 5000 samplings.

Results

Fourteen patients were identified, and the median age was 49.5 (range 1–70) years. There were eight male and six female patients. Four patients presented with Cushing’s syndrome, and half were diagnosed with stage IV ACC at presentation. Only three patients survived (21%). The median survival time was 15.5 (range 0.67–244) months. SSTR2 expression score > 50 (log-rank test: p = 0.009) and Ki-67 > 50% (log-rank test: p = 0.017) were associated with mortality. However, after adjusting for stage, the bootstrapping analysis demonstrated that Ki-67 [B 2.04, p = 0.004], Beta-catenin [B 2.19, p = 0.009], ATRX [B 1.48, p = 0.026], P53 [B 1.58, p = 0.027], SSTR2 [B 1.58, p = 0.015] and SSTR2 expression score [B 0.03, p < 0.001] were all significantly associated with mortality.

Conclusions

After adjusting for stage, Ki-67 > 50%, Beta-catenin, ATRX, P53, SSTR2 and SSTR2 expression score > 50 were associated with mortality in Asian patients with ACC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenocortical CarcinomaAdrenal Cortex NeoplasmsHumansMaleFemaleInfantChild, PreschoolChildAdolescentYoung AdultAdultMiddle AgedAgedbeta CateninKi-67 AntigenTumor Suppressor Protein p53Chlorophenols

Stichwörter der Autor:innen

Ki-67SSTRadrenocortical carcinomaimmunohistochemistry stain

Substanzen

beta CateninKi-67 AntigenTumor Suppressor Protein p532,5-dichloro-4-bromophenolChlorophenols

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, Department of Internal Medicine, MacKay Memorial Hospital, Taipei 104, Taiwan.
  • Department of Pathology, MacKay Memorial Hospital, Taipei 104, Taiwan.
  • Department of Medicine, MacKay Medical College, New Taipei City 252, Taiwan.

ORCID-Profile: Wen-Hsuan Tsai

Zitieren

APA

Tsai, W. H., Dai, S. H., Lee, C. C., Chien, M. N., & Zeng, Y. H. (2023). A Clinicopathological Analysis of Asian Patients with Adrenocortical Carcinoma: A Single-Center Experience. Current Oncology. https://doi.org/10.3390/curroncol30040313

Vancouver

Tsai WH, Dai SH, Lee CC, Chien MN, Zeng YH. A Clinicopathological Analysis of Asian Patients with Adrenocortical Carcinoma: A Single-Center Experience. Current Oncology. 2023. doi:10.3390/curroncol30040313

BibTeX
@article{Tsai2023,
  author = {Tsai, Wen-Hsuan and Dai, Shuen-Han and Lee, Chun-Chuan and Chien, Ming-Nan and Zeng, Yi-Hong},
  title = {A Clinicopathological Analysis of Asian Patients with Adrenocortical Carcinoma: A Single-Center Experience},
  journal = {Current Oncology},
  year = {2023},
  doi = {10.3390/curroncol30040313}
}
Kostenlos starten →